145 related articles for article (PubMed ID: 38266794)
1. COVID-19 plasma induces subcellular remodelling within the pulmonary microvascular endothelium.
Passi R; Cholewa-Waclaw J; Wereski R; Bennett M; Veizades S; Berkeley B; Caporali A; Li Z; Rodor J; Dewerchin M; Mills NL; Beqqali A; Brittan M; Baker AH
Vascul Pharmacol; 2024 Mar; 154():107277. PubMed ID: 38266794
[TBL] [Abstract][Full Text] [Related]
2. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
4. Role of Epithelial-Endothelial Cell Interaction in the Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Hui KP; Cheung MC; Lai KL; Ng KC; Ho JC; Peiris M; Nicholls JM; Chan MC
Clin Infect Dis; 2022 Jan; 74(2):199-209. PubMed ID: 33956935
[TBL] [Abstract][Full Text] [Related]
5. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
6. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
7. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
8. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.
Joffre J; Rodriguez L; Matthay ZA; Lloyd E; Fields AT; Bainton RJ; Kurien P; Sil A; Calfee CS; Woodruff PG; Erle DJ; Hendrickson C; Krummel MF; Langelier CR; Matthay MA; Kornblith LZ; Hellman J; ;
Am J Respir Crit Care Med; 2022 Oct; 206(8):961-972. PubMed ID: 35649173
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628764
[TBL] [Abstract][Full Text] [Related]
11. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs.
Won T; Wood MK; Hughes DM; Talor MV; Ma Z; Schneider J; Skinner JT; Asady B; Goerlich E; Halushka MK; Hays AG; Kim DH; Parikh CR; Rosenberg AZ; Coppens I; Johns RA; Gilotra NA; Hooper JE; Pekosz A; Čiháková D
EBioMedicine; 2022 Jan; 75():103812. PubMed ID: 35033854
[TBL] [Abstract][Full Text] [Related]
12. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
Sur S; Steele R; Isbell TS; Ray R; Ray RB
mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Targeting of IL-1-Signaling and IL-6-Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm-Brief Report.
Colás-Algora N; Muñoz-Pinillos P; Cacho-Navas C; Avendaño-Ortiz J; de Rivas G; Barroso S; López-Collazo E; Millán J
Arterioscler Thromb Vasc Biol; 2023 Nov; 43(11):2213-2222. PubMed ID: 37732482
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
[TBL] [Abstract][Full Text] [Related]
16. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
[TBL] [Abstract][Full Text] [Related]
17. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.
Wang P; Luo R; Zhang M; Wang Y; Song T; Tao T; Li Z; Jin L; Zheng H; Chen W; Zhao M; Zheng Y; Qin J
Cell Death Dis; 2020 Dec; 11(12):1042. PubMed ID: 33293527
[TBL] [Abstract][Full Text] [Related]
18. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.
Six I; Guillaume N; Jacob V; Mentaverri R; Kamel S; Boullier A; Slama M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682871
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.
Yoon H; Dean LS; Jiyarom B; Khadka VS; Deng Y; Nerurkar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
Front Immunol; 2023; 14():1268510. PubMed ID: 38259488
[TBL] [Abstract][Full Text] [Related]
20. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019.
Magro CM; Mulvey JJ; Laurence J; Seshan S; Crowson AN; Dannenberg AJ; Salvatore S; Harp J; Nuovo GJ
Hum Pathol; 2020 Dec; 106():106-116. PubMed ID: 33058948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
